 |
 |
 |
|
Antiretroviral Drug-Drug Interaction Profile of Long-Acting Cabotegravir and Rilpivirine
|
|
|
Pdf attached
Download the PDF here
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs Virtual Meeting, September 28-30, 2020
Reported by Jules Levin
Parul Patel,1 Jackie Bloomer,2 Kunal Taskar,2 Susan Ford,3 Herta Crauwels,4 Kelong Han,5
Stefaan Rossenu,4 David Margolis,1 Mark Baker6
1ViiV Healthcare, Research Triangle Park, NC, USA; 2GlaxoSmithKline, Ware, UK; 3GlaxoSmithKline, Research Triangle Park, NC, USA;
4Janssen Pharmaceutica NV, Research and Development, Beerse, Belgium; 5GlaxoSmithKline, Collegeville, PA, USA; 6ViiV Healthcare,
Nyon, Switzerland



|
|
|
 |
 |
|
|